Assessing GP use of varenicline therapy for smoking cessation
Vari M Drennan
Abstract
Vari M Drennan
Abstract
Smoking cessation is an important public health policy in reducing premature mortality in people with risk factors or comorbidities. Varenicline is the most effective therapy for sustained cessation, but it is not used as widely as nicotine replacement therapy.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Smoking cessation is an important public health policy in reducing premature mortality in people with risk factors or comorbidities. Varenicline is the most effective therapy for sustained cessation, but it is not used as widely as nicotine replacement therapy.
Key concepts: Varenicline, Smoking cessation, Nicotine replacement therapy, Medicine, Pharmacotherapy, Public health, Intensive care medicine, Psychiatry